Dr Dwight S Tyndall, MD - Medicare Orthopedic Surgery in Munster, IN

Dr Dwight S Tyndall, MD is a medicare enrolled "Orthopaedic Surgery - Orthopaedic Surgery Of The Spine" physician in Munster, Indiana. He went to New York Medical College and graduated in 1988 and has 36 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Lakeshore Bone And Joint Institute Ii, Llc, Rci (wrs), Llc. and his current practice location is 759 45th St, Munster, Indiana. You can reach out to his office (for appointments etc.) via phone at (219) 921-1444.

Dr Dwight S Tyndall is licensed to practice in Indiana (license number 01051714A) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1285643205.

Contact Information

Dr Dwight S Tyndall, MD
759 45th St,
Munster, IN 46321-2938
(219) 921-1444
(219) 921-5303



Physician's Profile

Full NameDr Dwight S Tyndall
GenderMale
SpecialityOrthopedic Surgery
Experience36 Years
Location759 45th St, Munster, Indiana
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Dwight S Tyndall attended and graduated from New York Medical College in 1988
  NPI Data:
  • NPI Number: 1285643205
  • Provider Enumeration Date: 08/07/2006
  • Last Update Date: 04/26/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 7618063306
  • Enrollment ID: I20071010000631

Medical Identifiers

Medical identifiers for Dr Dwight S Tyndall such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1285643205NPI-NPPES
200226250AMedicaidIN
140220OtherMEDICARE GROUP SMMN
90000692OtherBCIL GROUP
001051714OtherBCIL TYNDALL
104771OtherINANTHEM GROUP
5797564OtherAETNA
CI3318OtherRRMEDICARE GROUP
036095677MedicaidIL
1160572OtherFIRST HEALTH
200135850AOtherMEDICAID IND GROUP
00000092093OtherANTHEM
874640OtherINMEDICARE GROUP

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery 01051714A (Indiana)Secondary
207XS0117XOrthopaedic Surgery - Orthopaedic Surgery Of The Spine 01051714A (Indiana)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Franciscan Health MunsterMunster, INHospital
Northwest Health - PorterValparaiso, INHospital
Community HospitalMunster, INHospital
Pinnacle HospitalCrown point, INHospital
St Mary Medical Center IncHobart, INHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Lakeshore Bone And Joint Institute Ii, Llc04465129096
Rci (wrs), Llc.5092624510312

News Archive

Study helps reveal how nervous system modulates motor control patterns

Most people are impressed by how a toad jumps. UC Irvine biologist Emanuel Azizi is more impressed by how one lands. An assistant professor of ecology & evolutionary biology who specializes in muscle physiology and biomechanics, Azizi found that nature's favorite leapers possess a neuromuscular response that's specific to the intensity of a landing - a mechanism that protects muscles from injury upon impact.

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

Study explains how bacterial biofilms expand to form slimy mats on teeth, surgical instruments

New research at Harvard explains how bacterial biofilms expand to form slimy mats on teeth, pipes, surgical instruments, and crops.

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Dwight S Tyndall allows following entities to bill medicare on his behalf.
Entity NameLakeshore Bone & Joint Institute, Pc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1508853953
PECOS PAC ID: 3173500519
Enrollment ID: O20040702000362

News Archive

Study helps reveal how nervous system modulates motor control patterns

Most people are impressed by how a toad jumps. UC Irvine biologist Emanuel Azizi is more impressed by how one lands. An assistant professor of ecology & evolutionary biology who specializes in muscle physiology and biomechanics, Azizi found that nature's favorite leapers possess a neuromuscular response that's specific to the intensity of a landing - a mechanism that protects muscles from injury upon impact.

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

Study explains how bacterial biofilms expand to form slimy mats on teeth, surgical instruments

New research at Harvard explains how bacterial biofilms expand to form slimy mats on teeth, pipes, surgical instruments, and crops.

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

Read more Medical News

› Verified 7 days ago

Entity NameOrthopaedic Specialists Of Northwest Indiana Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1497865794
PECOS PAC ID: 5092788901
Enrollment ID: O20040818000914

News Archive

Study helps reveal how nervous system modulates motor control patterns

Most people are impressed by how a toad jumps. UC Irvine biologist Emanuel Azizi is more impressed by how one lands. An assistant professor of ecology & evolutionary biology who specializes in muscle physiology and biomechanics, Azizi found that nature's favorite leapers possess a neuromuscular response that's specific to the intensity of a landing - a mechanism that protects muscles from injury upon impact.

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

Study explains how bacterial biofilms expand to form slimy mats on teeth, surgical instruments

New research at Harvard explains how bacterial biofilms expand to form slimy mats on teeth, pipes, surgical instruments, and crops.

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

Read more Medical News

› Verified 7 days ago

Entity NameLakeshore Bone & Joint Institute Ii, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821326240
PECOS PAC ID: 0446512909
Enrollment ID: O20180320003388

News Archive

Study helps reveal how nervous system modulates motor control patterns

Most people are impressed by how a toad jumps. UC Irvine biologist Emanuel Azizi is more impressed by how one lands. An assistant professor of ecology & evolutionary biology who specializes in muscle physiology and biomechanics, Azizi found that nature's favorite leapers possess a neuromuscular response that's specific to the intensity of a landing - a mechanism that protects muscles from injury upon impact.

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

Study explains how bacterial biofilms expand to form slimy mats on teeth, surgical instruments

New research at Harvard explains how bacterial biofilms expand to form slimy mats on teeth, pipes, surgical instruments, and crops.

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Dwight S Tyndall is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Dwight S Tyndall, MD
601 Gateway Ave,
Chesterton, IN 46304

Ph: (219) 921-1444
Dr Dwight S Tyndall, MD
759 45th St,
Munster, IN 46321-2938

Ph: (219) 921-1444

News Archive

Study helps reveal how nervous system modulates motor control patterns

Most people are impressed by how a toad jumps. UC Irvine biologist Emanuel Azizi is more impressed by how one lands. An assistant professor of ecology & evolutionary biology who specializes in muscle physiology and biomechanics, Azizi found that nature's favorite leapers possess a neuromuscular response that's specific to the intensity of a landing - a mechanism that protects muscles from injury upon impact.

NexMed files IND with FDA for Phase II trial of PrevOnco for HCC

NexMed, Inc, a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco™, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC). The FDA has 30 days to comment on the IND before NexMed can proceed with human testing.

Study explains how bacterial biofilms expand to form slimy mats on teeth, surgical instruments

New research at Harvard explains how bacterial biofilms expand to form slimy mats on teeth, pipes, surgical instruments, and crops.

Extra dose of proton radiation therapy reduces prostate cancer recurrences

Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.

Read more News

› Verified 7 days ago


Orthopaedic Surgery Doctors in Munster, IN

Dr. Prasit Sri, M.D.
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 9034 Columbia Ave, Munster, IN 46321
Phone: 219-836-0296    Fax: 219-836-0570
Dr. Brian John Evanson, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 9445 Calumet Ave, Munster, IN 46321
Phone: 219-836-1060    
Dr. Gregory P. Mccomis, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 9445 Calumet Ave, Munster, IN 46321
Phone: 219-836-1060    Fax: 219-836-1014
Daniel Woods, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 730 45th Ave, Munster, IN 46321
Phone: 219-924-3300    Fax: 219-934-2658
Michael Knesek, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 9445 Calumet Ave, Munster, IN 46321
Phone: 219-836-1060    Fax: 219-836-1014
Upendra H. Patel, M.D.
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 8242 Calumet Ave., Munster, IN 46321
Phone: 219-836-6166    Fax: 219-836-0768

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.